![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Pharmacokinetics of Darunavir, Ombitasvir, Paritaprevir, Ritonavir, Dasabuvir and Ribavirin in Adults Infected with Hepatitis C Virus (HCV) Genotype 1 and Human Immunodeficiency Virus (HIV)
|
|
|
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy
Washington D.C., June 8-10, 2016
Jennifer R King, Amit Khatri, Roger Trinh, Bifeng
Ding, Jiuhong Zha and Rajeev Menon
AbbVie Inc.
![Clin1](../images/062916/062916-5/Clin1.gif)
![Clin2](../images/062916/062916-5/Clin2.gif)
![Clin3](../images/062916/062916-5/Clin3.gif)
![Clin4](../images/062916/062916-5/Clin4.gif)
![Clin5](../images/062916/062916-5/Clin5.gif)
![Clin6](../images/062916/062916-5/Clin6.gif)
![Clin7](../images/062916/062916-5/Clin7.gif)
![Clin8](../images/062916/062916-5/Clin8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|